Crispr Therapeutics AG (CRSPN) Q3 2024 Earnings Report
MX:CRSPN Q3 2024 EPS Results
- Actual EPS
- -MXN 18.77
- Consensus EPS
- -MXN 26.16
- Beat/Miss
- Beat by +MXN 7.40
- One Year Ago EPS
- -MXN 26.20
MX:CRSPN Q3 2024 Revenue Results
- Actual Revenue
- MXN 11.19M
- Expected Revenue
- MXN 121.54M
- Beat/Miss
- Missed by -MXN 110.35M
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2024
- Date
- 11/05/2024
- Time
- Before Open
- Conference Call
- Tuesday, November 5, 2024
MX:CRSPN Upcoming Earnings
Crispr Therapeutics AG's next earnings date is estimated for February 16, 2027, based on past reporting schedules.
Q3 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:CRSPN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 16, 2027 | 2026 (Q4) | -22.32- | -25.46 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | -19.27-21.37 | -21.74 | 1.71% (+0.37) | |
| Aug 03, 2026 | 2026 (Q2) | -22.20-17.47 | -44.59 | 60.83% (+27.13) | |
| May 04, 2026 | 2026 (Q1) | -22.63-23.78 | -29.36 | 18.99% (+5.57) | |
| Feb 12, 2026 | 2025 (Q4) | -21.61-25.46 | -8.18 | -211.36% (-17.28) | |
| Nov 10, 2025 | 2025 (Q3) | -23.50-21.74 | -18.77 | -15.84% (-2.97) | |
| Aug 04, 2025 | 2025 (Q2) | -26.05-44.59 | -27.69 | -61.07% (-16.91) | |
| May 06, 2025 | 2025 (Q1) | -23.11-29.36 | -26.57 | -10.49% (-2.79) | |
| Feb 11, 2025 | 2024 (Q4) | -22.32-8.18 | 20.44 | -140.00% (-28.61) | |
| Nov 05, 2024 | 2024 (Q3) | -26.16-18.77 | -26.2 | 28.37% (+7.43) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
